Last reviewed · How we verify

NCT04677023

Evaluation of Organically Modified Ceramic Resin Composite Versus Bulkfill Resin in Proximal Posterior Cavities

Status unknown NA Last updated 23 December 2020
What this trial tests

NA trial testing GrandioSO x-tra® bulk in Proximal Caries in 22 participants. Status unknown.

Timeline
1 January 2021
Primary endpoint
1 January 2022
1 February 2022

Quick facts

Lead sponsorCairo University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment22
Start date1 January 2021
Primary completion1 January 2022
Estimated completion1 February 2022

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 18 to 60, any sex, with Proximal Caries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In patients with compound posterior proximal cavities, will the use of organically modified ceramic resin composite restorative material have similar clinical performance to conventional bulk fill resin composite, evaluation of restorations will be done at baseline,six and twelve months using World Dental Federation FDI criteria.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Proximal Caries

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04677023.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing